Yuichiro Yano1, Rikki M Tanner2, Swati Sakhuja2, Byron C Jaeger3, John N Booth2, Marwah Abdalla4, Daniel Pugliese4, Samantha R Seals5, Gbenga Ogedegbe6, Daniel W Jones7, Paul Muntner2, Daichi Shimbo4. 1. Department of Family Medicine and Community Health, Duke University, Durham, North Carolina. 2. Department of Epidemiology, University of Alabama at Birmingham, Birmingham. 3. Department of Biostatistics, University of Alabama at Birmingham, Birmingham. 4. Department of Medicine, Columbia University, New York, New York. 5. Department of Mathematics and Statistics, University of West Florida, Pensacola. 6. Department of Population Health, New York University School of Medicine, New York. 7. Mississippi Center for Obesity Research, University of Mississippi Medical Center, Jackson.
Abstract
Importance: Little is known regarding health outcomes associated with higher blood pressure (BP) levels measured outside the clinic among African American individuals. Objective: To examine whether daytime and nighttime BP levels measured outside the clinic among African American individuals are associated with cardiovascular disease (CVD) and all-cause mortality independent of BP levels measured inside the clinic. Design, Setting, and Participants: This prospective cohort study analyzed data from 1034 African American participants in the Jackson Heart Study who completed ambulatory BP monitoring at baseline (September 26, 2000, to March 31, 2004). Mean daytime and nighttime BPs were calculated based on measurements taken while participants were awake and asleep, respectively. Data were analyzed from July 1, 2017, to April 30, 2019. Main Outcomes and Measures: Cardiovascular disease events, including coronary heart disease and stroke, experienced through December 31, 2014, and all-cause mortality experienced through December 31, 2016, were adjudicated. The associations of daytime BP and nighttime BP, separately, with CVD events and all-cause mortality were determined using Cox proportional hazards regression models. Results: A total of 1034 participants (mean [SD] age, 58.9 [10.9] years; 337 [32.6%] male; and 583 [56.4%] taking antihypertensive medication) were included in the study. The mean daytime systolic BP (SBP)/diastolic BP (DBP) was 129.4/77.6 mm Hg, and the mean nighttime SBP/DBP was 121.3/68.4 mm Hg. During follow-up (median [interquartile range], 12.5 [11.1-13.6] years for CVD and 14.8 [13.7-15.6] years for all-cause mortality), 113 CVD events and 194 deaths occurred. After multivariable adjustment, including in-clinic SBP and DBP, the hazard ratios (HRs) for CVD events for each SD higher level were 1.53 (95% CI, 1.24-1.88) for daytime SBP (per 13.5 mm Hg), 1.48 (95% CI, 1.22-1.80) for nighttime SBP (per 15.5 mm Hg), 1.25 (95% CI, 1.02-1.51) for daytime DBP (per 9.3 mm Hg), and 1.30 (95% CI, 1.06-1.59) for nighttime DBP (per 9.5 mm Hg). Nighttime SBP was associated with all-cause mortality (HR per 1-SD higher level, 1.24; 95% CI, 1.06-1.45), but no association was present for daytime SBP (HR, 1.13; 95% CI, 0.97-1.33) and daytime (HR, 0.95; 95% CI, 0.81-1.10) and nighttime (HR, 1.06; 95% CI, 0.90-1.24) DBP. Conclusions and Relevance: Among African American individuals, higher daytime and nighttime SBPs were associated with an increased risk for CVD events and all-cause mortality independent of BP levels measured in the clinic. Measurement of daytime and nighttime BP using ambulatory monitoring during a 24-hour period may help identify African American individuals who have an increased cardiovascular disease risk.
Importance: Little is known regarding health outcomes associated with higher blood pressure (BP) levels measured outside the clinic among African American individuals. Objective: To examine whether daytime and nighttime BP levels measured outside the clinic among African American individuals are associated with cardiovascular disease (CVD) and all-cause mortality independent of BP levels measured inside the clinic. Design, Setting, and Participants: This prospective cohort study analyzed data from 1034 African American participants in the Jackson Heart Study who completed ambulatory BP monitoring at baseline (September 26, 2000, to March 31, 2004). Mean daytime and nighttime BPs were calculated based on measurements taken while participants were awake and asleep, respectively. Data were analyzed from July 1, 2017, to April 30, 2019. Main Outcomes and Measures: Cardiovascular disease events, including coronary heart disease and stroke, experienced through December 31, 2014, and all-cause mortality experienced through December 31, 2016, were adjudicated. The associations of daytime BP and nighttime BP, separately, with CVD events and all-cause mortality were determined using Cox proportional hazards regression models. Results: A total of 1034 participants (mean [SD] age, 58.9 [10.9] years; 337 [32.6%] male; and 583 [56.4%] taking antihypertensive medication) were included in the study. The mean daytime systolic BP (SBP)/diastolic BP (DBP) was 129.4/77.6 mm Hg, and the mean nighttime SBP/DBP was 121.3/68.4 mm Hg. During follow-up (median [interquartile range], 12.5 [11.1-13.6] years for CVD and 14.8 [13.7-15.6] years for all-cause mortality), 113 CVD events and 194 deaths occurred. After multivariable adjustment, including in-clinic SBP and DBP, the hazard ratios (HRs) for CVD events for each SD higher level were 1.53 (95% CI, 1.24-1.88) for daytime SBP (per 13.5 mm Hg), 1.48 (95% CI, 1.22-1.80) for nighttime SBP (per 15.5 mm Hg), 1.25 (95% CI, 1.02-1.51) for daytime DBP (per 9.3 mm Hg), and 1.30 (95% CI, 1.06-1.59) for nighttime DBP (per 9.5 mm Hg). Nighttime SBP was associated with all-cause mortality (HR per 1-SD higher level, 1.24; 95% CI, 1.06-1.45), but no association was present for daytime SBP (HR, 1.13; 95% CI, 0.97-1.33) and daytime (HR, 0.95; 95% CI, 0.81-1.10) and nighttime (HR, 1.06; 95% CI, 0.90-1.24) DBP. Conclusions and Relevance: Among African American individuals, higher daytime and nighttime SBPs were associated with an increased risk for CVD events and all-cause mortality independent of BP levels measured in the clinic. Measurement of daytime and nighttime BP using ambulatory monitoring during a 24-hour period may help identify African American individuals who have an increased cardiovascular disease risk.
Authors: John N Booth; Keith M Diaz; Samantha R Seals; Mario Sims; Joseph Ravenell; Paul Muntner; Daichi Shimbo Journal: Hypertension Date: 2016-06-27 Impact factor: 10.190
Authors: J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster Journal: JAMA Date: 1999-08-11 Impact factor: 56.272
Authors: Joseph Ravenell; Daichi Shimbo; John N Booth; Daniel F Sarpong; Charles Agyemang; Danielle L Beatty Moody; Marwah Abdalla; Tanya M Spruill; Amanda J Shallcross; Adam P Bress; Paul Muntner; Gbenga Ogedegbe Journal: Circulation Date: 2017-04-20 Impact factor: 29.690
Authors: George C Roush; Robert H Fagard; Gil F Salles; Sante D Pierdomenico; Gianpaolo Reboldi; Paolo Verdecchia; Kazuo Eguchi; Kazuomi Kario; Satoshi Hoshide; Jorge Polonia; Alejandro de la Sierra; Ramon C Hermida; Eamon Dolan; Hernan Zamalloa Journal: J Hypertens Date: 2014-12 Impact factor: 4.844
Authors: Samantha R Seals; Lisandro D Colantonio; Jonathan V Tingle; Daichi Shimbo; Adolfo Correa; Michael E Griswold; Paul Muntner Journal: Blood Press Monit Date: 2019-06 Impact factor: 1.444
Authors: Shia T Kent; Daichi Shimbo; Lei Huang; Keith M Diaz; Anthony J Viera; Meredith Kilgore; Suzanne Oparil; Paul Muntner Journal: J Am Soc Hypertens Date: 2014-10-02
Authors: Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad Journal: J Hypertens Date: 2013-07 Impact factor: 4.844
Authors: Samantha G Bromfield; John N Booth; Matthew S Loop; Joseph E Schwartz; Samantha R Seals; Stephen J Thomas; Yuan-I Min; Gbenga Ogedegbe; Daichi Shimbo; Paul Muntner Journal: Blood Press Monit Date: 2018-04 Impact factor: 1.444
Authors: Paul Muntner; Cora E Lewis; Keith M Diaz; April P Carson; Yongin Kim; David Calhoun; Yuichiro Yano; Anthony J Viera; Daichi Shimbo Journal: Am J Hypertens Date: 2014-11-04 Impact factor: 3.080
Authors: Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright Journal: Hypertension Date: 2017-11-13 Impact factor: 9.897
Authors: Yuichiro Yano; Bharat Poudel; Ligong Chen; Swati Sakhuja; Byron C Jaeger; Anthony J Viera; Daichi Shimbo; Donald Clark; David Edmund Anstey; Feng-Chang Lin; Cora E Lewis; James M Shikany; Jamal S Rana; Adolfo Correa; Donald M Lloyd-Jones; Joseph E Schwartz; Paul Muntner Journal: Am J Hypertens Date: 2022-07-01 Impact factor: 3.080
Authors: Byron C Jaeger; Oluwasegun P Akinyelure; Swati Sakhuja; Joshua D Bundy; Cora E Lewis; Yuichiro Yano; George Howard; Daichi Shimbo; Paul Muntner; Joseph E Schwartz Journal: Hypertens Res Date: 2021-08-11 Impact factor: 5.528
Authors: Mark K Santillan; Richard C Becker; David A Calhoun; Allen W Cowley; Joseph T Flynn; Justin L Grobe; Theodore A Kotchen; Daniel T Lackland; Kimberly K Leslie; Mingyu Liang; David L Mattson; Kevin E Meyers; Mark M Mitsnefes; Paul M Muntner; Gary L Pierce; Jennifer S Pollock; Curt D Sigmund; Stephen J Thomas; Elaine M Urbina; Srividya Kidambi Journal: Hypertension Date: 2021-05-03 Impact factor: 9.897
Authors: Joshua J Joseph; Neal K Pohlman; Songzhu Zhao; David Kline; Guy Brock; Justin B Echouffo-Tcheugui; Mario Sims; Valery S Effoe; Wen-Chih Wu; Rita R Kalyani; Gary S Wand; Bjorn Kluwe; Willa A Hsueh; Marwah Abdalla; Daichi Shimbo; Sherita H Golden Journal: Circulation Date: 2021-02-19 Impact factor: 39.918
Authors: Joshua D Bundy; Byron C Jaeger; Mark D Huffman; Sarah S Knox; S Justin Thomas; Daichi Shimbo; John N Booth; Cora E Lewis; Lloyd J Edwards; Joseph E Schwartz; Paul Muntner Journal: Am J Hypertens Date: 2021-05-22 Impact factor: 3.080
Authors: Swati Sakhuja; John N Booth; David E Anstey; Byron C Jaeger; Cora E Lewis; Donald M Lloyd-Jones; Joseph E Schwartz; Daichi Shimbo; James M Shikany; Mario Sims; Paul Muntner Journal: Am J Hypertens Date: 2020-11-03 Impact factor: 3.080